National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

paclitaxel vitamin E-based emulsion formulation
A cremophor-free, P-glycoprotein-inhibiting, vitamin E-based emulsion particle formulation of paclitaxel with antineoplastic activity. Paclitaxel binds to tubulin and inhibits the disassembly of microtubules, thereby resulting in the inhibition of cell division. This agent also induces apoptosis by binding to and blocking the function of the apoptosis inhibitor protein Bcl-2 (B-cell Leukemia 2). The vitamin-E based emulsion allows bolus infusion without steroid premedication and may diminish hypersensitivity reactions; tumor tissue may be passively targeted due to preferential deposition of emulsion particles while an emulsion formulation component inhibits the P-glycoprotein drug efflux pump. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

US brand name:Tocosol Paclitaxel
Code name:S-8184



Previous:OxyContin, p53 peptide vaccine, paclitaxel, paclitaxel albumin-stabilized nanoparticle formulation, paclitaxel poliglumex
Next:paclitaxel-loaded polymeric micelle, padeliporfin, PADRE 965.10, PADRE-CMV fusion peptide vaccine, Palestrol

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov